Access Biotechnology
New York City, New Yorkaccessindustries.com
Overview
Access Biotechnology is the life science investment arm of Access Industries, investing in both private and public biopharma companies developing transformative therapies for conditions with high unmet needs.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Recludix Pharma | Jan 2026 | Series B | Lead |
| Hemab Therapeutics | Oct 2025 | Series C | Co-investor |
| Hemab Therapeutics | Oct 2025 | Series C | Co-investor |
| Treeline Biosciences | Sep 2025 | Series A | Co-investor |
| Draig Therapeutics | Jun 2025 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
